Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Roger Stupp

1-50 of 227 results

View this query on the Wikidata Query Service
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

scientific article (publication date: 10 March 2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma

scientific article
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

scientific article published on March 15, 2010
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

scientific article
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

scientific article
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

scientific article published on March 2004
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

scientific article
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

scientific article published on September 2008
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

scientific article
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial

scientific article published on 07 October 2013
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

scientific article published on 08 December 2009
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

scientific article
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

scientific article published in August 2014
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

scientific article published on 21 December 2007
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

scientific article published in June 2006
Chemoradiotherapy in malignant glioma: standard of care and future directions

scientific article
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule

scientific article published on 19 February 2004
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

scientific article
Current concepts and management of glioblastoma

scientific article published on July 2011
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

scientific article published in December 2017
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

scientific article published on 18 May 2012
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

scientific article published on 22 August 2017
Changing paradigms--an update on the multidisciplinary management of malignant glioma

scientific article
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

scientific article published on 5 May 2017
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

scientific article
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

scientific article
Health-related quality of life in patients with glioblastoma: a randomised controlled trial

scientific article published on December 2005
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

scientific article
Lomustine and Bevacizumab in Progressive Glioblastoma

scientific article published in November 2017
Phase II study of imatinib in advanced chordoma

scientific article published on 13 February 2012
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

scientific article published on October 2003
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98

scientific article
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

scientific article published on August 2006
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

scientific article published on October 2008
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

scientific article published on 28 March 2012
Molecular neuro-oncology in clinical practice: a new horizon

scientific article published on August 2013
Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

scientific article published on May 1, 2003
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

scientific article published on 5 February 2015
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker

scientific article published on 8 April 2008
Glioma.

scientific article published on 16 July 2015
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

scientific article published on 26 September 2016
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

scientific article published on 01 August 2008
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

scientific article
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

scientific article published in April 2002
Optimal role of temozolomide in the treatment of malignant gliomas.

scientific article
Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments

scientific article published on February 2008
Corticosteroids compromise survival in glioblastoma

scientific article
Recent developments in the use of chemotherapy in brain tumours.

scientific article published on 20 January 2006
Bevacizumab and recurrent malignant gliomas: a European perspective

scientific article
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia

scientific article

Paulina is supported by:

About Paulina

Help